Holder of Certificate of Registration (HCR)
Applicants must appoint a local South African legal entity as the HCR to take responsibility for the product.
The South African Health Products Regulatory Authority (SAHPRA) is the national regulatory body responsible for ensuring the safety, efficacy, and quality of medicines, medical devices, in vitro diagnostics (IVDs), and radiation-emitting devices in South Africa. Registration with SAHPRA is mandatory for pharmaceutical companies, manufacturers, and distributors planning to enter or operate in the South African market
Pharmacovigilance: Mandatory reporting of adverse drug reactions (ADRs) and quality issues via the Med Safety App or to SAHPRA.
Variations
Post-approval changes must be submitted via the Variation Addendum process
Navigating SAHPRA Registration:
Entering the South African pharmaceutical and medical device market requires navigating complex, yet structured, regulatory requirements set by the South African Health Products Regulatory Authority (SAHPRA). As the national regulatory authority, SAHPRA ensures that all health products—medicines, medical devices, and in vitro diagnostics (IVDs)—meet stringent safety, quality, and efficacy standards.
For foreign manufacturers and local distributors, partnering with an experienced regulatory consultancy is the fastest way to bridge compliance gaps and secure market access.
Key Regulatory Areas:
We provide end-to-end consulting for all SAHPRA-regulated products:
Medical Device & IVD Registration